tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMPX Stock Latest News

Compass Therapeutics: Strengthening Clinical Pipeline and 2026 Milestones Underscore Buy Rating and Upside Potential
RatingsCompass Therapeutics: Strengthening Clinical Pipeline and 2026 Milestones Underscore Buy Rating and Upside Potential
4d ago
CMPX
Compass Therapeutics: Strong Cash Position and 2026 Clinical Catalysts Underpin Reiterated Buy Rating
PremiumRatings
Compass Therapeutics: Strong Cash Position and 2026 Clinical Catalysts Underpin Reiterated Buy Rating
8d ago
CMPX
Compass Therapeutics provides corporate update
PremiumThe Fly
Compass Therapeutics provides corporate update
8d ago
CMPX
Compass Therapeutics details cash runway and pipeline progress
PremiumCompany Announcements
Compass Therapeutics details cash runway and pipeline progress
8d ago
8K
CMPX
Compass Therapeutics appoints Arjun Prasad as CCO, Cynthia Sirard as CMO
PremiumThe Fly
Compass Therapeutics appoints Arjun Prasad as CCO, Cynthia Sirard as CMO
9d ago
CMPX
Compass Therapeutics initiated with an Outperform at William Blair
PremiumThe FlyCompass Therapeutics initiated with an Outperform at William Blair
10d ago
CMPX
Compass Therapeutics: Emerging Bispecific Portfolio Positions Tovecimig to Redefine Second-Line Biliary Tract Cancer Standard of Care
Premium
Ratings
Compass Therapeutics: Emerging Bispecific Portfolio Positions Tovecimig to Redefine Second-Line Biliary Tract Cancer Standard of Care
10d ago
CMPX
High-Conviction Buy on Compass Therapeutics: Near-Term Tovecimig Registration Data and Differentiated PD-1 x PD-L1 Bispecific Drive Favorable Risk-Reward
Premium
Ratings
High-Conviction Buy on Compass Therapeutics: Near-Term Tovecimig Registration Data and Differentiated PD-1 x PD-L1 Bispecific Drive Favorable Risk-Reward
10d ago
CMPX
Compass Therapeutics files $400M mixed securities shelf
PremiumThe Fly
Compass Therapeutics files $400M mixed securities shelf
15d ago
CMPX
Promising Clinical Data and Market Positioning Drive Buy Rating for Compass Therapeutics
PremiumRatings
Promising Clinical Data and Market Positioning Drive Buy Rating for Compass Therapeutics
29d ago
CMPX
Canaccord starts Compass Therapeutics with a Buy ahead of tovecimig readout
PremiumThe Fly
Canaccord starts Compass Therapeutics with a Buy ahead of tovecimig readout
1M ago
CMPX
Compass Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Compass Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
CMPX
Compass Therapeutics initiated with a Buy at Canaccord
PremiumThe FlyCompass Therapeutics initiated with a Buy at Canaccord
1M ago
CMPX
Compass Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Compass Therapeutics initiated with an Outperform at Citizens JMP
1M ago
CMPX
Compass Therapeutics’ CTX-10726: A Promising Leader in the Competitive PD-1 and VEGF Markets
Premium
Ratings
Compass Therapeutics’ CTX-10726: A Promising Leader in the Competitive PD-1 and VEGF Markets
2M ago
CMPX
Compass Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Compass Therapeutics Reports Q3 2025 Financial Results
2M ago
CMPX
Positive Outlook for Compass Therapeutics: Buy Rating Justified by Promising Developments and Strong Financial Position
PremiumRatings
Positive Outlook for Compass Therapeutics: Buy Rating Justified by Promising Developments and Strong Financial Position
2M ago
CMPX
Compass Therapeutics reports Q3 EPS (8c), consensus (13c)
PremiumThe Fly
Compass Therapeutics reports Q3 EPS (8c), consensus (13c)
2M ago
CMPX
Compass Therapeutics presents preclinical data on CTX-10726
PremiumThe Fly
Compass Therapeutics presents preclinical data on CTX-10726
2M ago
CMPX
Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment
PremiumCompany AnnouncementsCompass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment
3M ago
CMPX
Compass Therapeutics management to meet with Piper Sandler
Premium
The Fly
Compass Therapeutics management to meet with Piper Sandler
3M ago
CMPX
Promising Outlook for Compass Therapeutics: Buy Rating Backed by COMPANION-002 Trial Success and Market Potential
Premium
Ratings
Promising Outlook for Compass Therapeutics: Buy Rating Backed by COMPANION-002 Trial Success and Market Potential
3M ago
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >